Patents by Inventor Michael Harvey Greenspan
Michael Harvey Greenspan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11771669Abstract: The described invention provides a topical delivery system comprising a pharmaceutical composition for application directly to a skin of a subject in need thereof comprising (a) an effective therapeutic amount of an active therapeutic agent; (b) chemical drivers comprising an amino benzoate local anesthetic, ethoxydiglycol and methylsulfonylmethane (MSM) that in combination are effective to synergistically deliver the therapeutic agent; and (c) a depot component for keeping the pharmaceutical composition in the skin. Methods for delivering an active therapeutic agent into skin, for keeping it in the skin, for reducing systemic side effects attributable to entry of the active agent into the blood stream, and a method for treating a condition, disease or disorder of skin topically also are described in accordance with the embodiments of the described invention.Type: GrantFiled: May 5, 2021Date of Patent: October 3, 2023Assignee: SBG MEDICAL TECHNOLOGIES, INC.Inventor: Michael Harvey Greenspan
-
Publication number: 20230210787Abstract: The described invention provides a method of treating localized pain comprising (a) applying topically to an area of skin of a subject overlaying the localized pain a pharmaceutical composition comprising a cannabinoid component and a chemical driver component comprising two or more of methylsulfonylmethane (MSM), and ethoxydiglycol, and propylene glycol; and applying an external energy effective to enhance transdermal permeation of the pharmaceutical composition into the skin. wherein the components of the composition and the device are cooperatively effective to work together to maximize transdermal delivery of the composition, deeply penetrate the skin of the subject and to provide pain relief.Type: ApplicationFiled: March 9, 2023Publication date: July 6, 2023Applicant: SBG MEDICAL TECHNOLOGIES, INC.Inventors: Michael Harvey Greenspan, Christopher P. Norval
-
Publication number: 20210251926Abstract: The described invention provides a topical delivery system comprising a pharmaceutical composition for application directly to a skin of a subject in need thereof comprising (a) an effective therapeutic amount of an active therapeutic agent; (b) chemical drivers comprising an amino benzoate local anesthetic, ethoxydiglycol and methylsulfonylmethane (MSM) that in combination are effective to synergistically deliver the therapeutic agent; and (c) a depot component for keeping the pharmaceutical composition in the skin. Methods for delivering an active therapeutic agent into skin, for keeping it in the skin, for reducing systemic side effects attributable to entry of the active agent into the blood stream, and a method for treating a condition, disease or disorder of skin topically also are described in accordance with the embodiments of the described invention.Type: ApplicationFiled: May 5, 2021Publication date: August 19, 2021Applicant: Sambria Pharmaceuticals, LLCInventor: Michael Harvey Greenspan
-
Patent number: 11026902Abstract: The described invention provides a topical delivery system comprising a pharmaceutical composition for application directly to a skin of a subject in need thereof comprising (a) an effective therapeutic amount of an active therapeutic agent; (b) chemical drivers comprising an amino benzoate local anesthetic, ethoxydiglycol and methylsulfonylmethane (MSM) that in combination are effective to synergistically deliver the therapeutic agent; and (c) a depot component for keeping the pharmaceutical composition in the skin. Methods for delivering an active therapeutic agent into skin, for keeping it in the skin, for reducing systemic side effects attributable to entry of the active agent into the blood stream, and a method for treating a condition, disease or disorder of skin topically also are described in accordance with the embodiments of the described invention.Type: GrantFiled: March 4, 2019Date of Patent: June 8, 2021Assignee: SAMBRIA PHARMACEUTICALS, LLCInventor: Michael Harvey Greenspan
-
Publication number: 20210015740Abstract: The described invention provides pharmaceutical compositions and a topical delivery system comprising a pharmaceutical composition for application directly to a skin of a subject in need thereof, the composition comprising (a) a therapeutic amount of an active agent comprising one or more of a cannabinoid, a counterirritant and an amino benzoate local anesthetic; (b) a chemical driver component comprising two or more of ethoxydiglycol, methylsulfonylmethane (MSM), propylene glycol, that in combination are cooperatively effective to deliver the therapeutic agent; and optionally (c) a depot component for keeping the composition in the skin. Methods for delivering an active therapeutic agent into skin, for keeping it in the skin, for reducing systemic side effects attributable to entry of the active agent into the blood stream, and a method for treating a condition, disease or disorder of skin topically also are described in accordance with the embodiments of the described invention.Type: ApplicationFiled: September 29, 2020Publication date: January 21, 2021Inventors: Michael Harvey Greenspan, Christopher P. Norval
-
Publication number: 20190374491Abstract: A composition for pain relief including synergistically effective amounts of an amino benzoate local anesthetic, methylsulfonylmethane (MSM), and ethoxydiglycol. A method of treating pain, by applying the composition to skin in an area of pain, and blocking nerve signals. A method of improving range of motion in an individual, by applying the composition to skin, relieving pain, and allowing the individual to have an improved range of motion at an area of pain.Type: ApplicationFiled: July 31, 2019Publication date: December 12, 2019Applicant: Sambria Pharmaceuticals, LLCInventor: Michael Harvey Greenspan
-
Patent number: 10391074Abstract: A composition for pain relief including synergistically effective amounts of an amino benzoate local anesthetic, methylsulfonylmethane (MSM), and ethoxydiglycol. A method of treating pain, by applying the composition to skin in an area of pain, and blocking nerve signals. A method of improving range of motion in an individual, by applying the composition to skin, relieving pain, and allowing the individual to have an improved range of motion at an area of pain.Type: GrantFiled: December 6, 2013Date of Patent: August 27, 2019Assignee: Sambria Pharmaceuticals, LLCInventor: Michael Harvey Greenspan
-
Publication number: 20190254999Abstract: The described invention provides a topical delivery system comprising a pharmaceutical composition for application directly to a skin of a subject in need thereof comprising (a) an effective therapeutic amount of an active therapeutic agent; (b) chemical drivers comprising an amino benzoate local anesthetic, ethoxydiglycol and methylsulfonylmethane (MSM) that in combination are effective to synergistically deliver the therapeutic agent; and (c) a depot component for keeping the pharmaceutical composition in the skin. Methods for delivering an active therapeutic agent into skin, for keeping it in the skin, for reducing systemic side effects attributable to entry of the active agent into the blood stream, and a method for treating a condition, disease or disorder of skin topically also are described in accordance with the embodiments of the described invention.Type: ApplicationFiled: March 4, 2019Publication date: August 22, 2019Applicant: Sambria Pharmaceuticals, LLCInventor: Michael Harvey Greenspan
-
Patent number: 10265283Abstract: The described invention provides a topical delivery system comprising a pharmaceutical composition for application directly to a skin of a subject in need thereof comprising (a) an effective therapeutic amount of an active therapeutic agent; (b) chemical drivers comprising an amino benzoate local anesthetic, ethoxydiglycol and methylsulfonylmethane (MSM) that in combination are effective to synergistically deliver the therapeutic agent; and (c) a depot component for keeping the pharmaceutical composition in the skin. Methods for delivering an active therapeutic agent into skin, for keeping it in the skin, for reducing systemic side effects attributable to entry of the active agent into the blood stream, and a method for treating a condition, disease or disorder of skin topically also are described in accordance with the embodiments of the described invention.Type: GrantFiled: February 3, 2016Date of Patent: April 23, 2019Assignee: Sambria Pharmaceuticals, LLCInventor: Michael Harvey Greenspan
-
Publication number: 20160151313Abstract: The described invention provides a topical delivery system comprising a pharmaceutical composition for application directly to a skin of a subject in need thereof comprising (a) an effective therapeutic amount of an active therapeutic agent; (b) chemical drivers comprising an amino benzoate local anesthetic, ethoxydiglycol and methylsulfonylmethane (MSM) that in combination are effective to synergistically deliver the therapeutic agent; and (c) a depot component for keeping the pharmaceutical composition in the skin. Methods for delivering an active therapeutic agent into skin, for keeping it in the skin, for reducing systemic side effects attributable to entry of the active agent into the blood stream, and a method for treating a condition, disease or disorder of skin topically also are described in accordance with the embodiments of the described invention.Type: ApplicationFiled: February 3, 2016Publication date: June 2, 2016Inventor: Michael Harvey Greenspan
-
Publication number: 20140163105Abstract: A composition for pain relief including synergistically effective amounts of an amino benzoate local anesthetic, methylsulfonylmethane (MSM), and ethoxydiglycol. A method of treating pain, by applying the composition to skin in an area of pain, and blocking nerve signals. A method of improving range of motion in an individual, by applying the composition to skin, relieving pain, and allowing the individual to have an improved range of motion at an area of pain.Type: ApplicationFiled: December 6, 2013Publication date: June 12, 2014Inventor: Michael Harvey Greenspan